Sotyktu

Sotyktu (deucravacitinib) is an oral medication used for managing certain inflammatory conditions. This prescription treatment helps reduce symptoms associated with immune-mediated disorders. It is designed for adults and requires medical supervision for safe use.

Sotyktu (deucravacitinib) is primarily used to treat moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy. It works by targeting specific pathways involved in the inflammatory process. This medication is also being studied for other immune-mediated conditions, though its approved use remains focused on plaque psoriasis at this time.

Sotyktu (deucravacitinib) helps reduce inflammation and skin-related symptoms such as redness, scaling, and itching. Users may notice an improvement in skin appearance and comfort over time. Individual responses to the medication can vary, and consistent use is important for optimal results.

Sotyktu (deucravacitinib) should be taken exactly as prescribed by a healthcare provider. Patients should inform their doctor about any existing medical conditions, especially infections or liver problems. Regular monitoring may be required to ensure safe and effective use. Avoid starting or stopping other medications without consulting a healthcare professional.

Sotyktu (deucravacitinib) may interact with other drugs that affect the immune system or certain enzymes in the liver. Combining it with strong immunosuppressants or CYP inhibitors could alter its effectiveness or increase side effects. Always discuss current medications with a doctor before starting this treatment.